Linked Data API

Show Search Form

Search Results

1521761
human indexable true more like this
published true more like this
registered interest false more like this
answer date less than 2022-10-19more like thismore than 2022-10-19
date less than 2022-10-13more like thismore than 2022-10-13
date tabled less than 2022-10-13more like thismore than 2022-10-13
ddp created less than 2022-10-13T17:13:50.627Zmore like thismore than 2022-10-13T17:13:50.627Z
answering body
Department of Health and Social Care more like this
question status Tabled more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
ddp modified
less than 2022-10-14T14:05:49.840Zmore like thismore than 2022-10-14T14:05:49.840Z
less than 2023-08-22T08:37:31.028Zmore like thismore than 2023-08-22T08:37:31.028Z
hansard heading Non-tuberculous Mycobacteria: Medical Treatments remove filter
house id 1 more like this
identifier 62682 more like this
legislature
25259
parliament number 58 more like this
question first answered
less than 2023-08-22T08:06:30.753Zmore like thismore than 2023-08-22T08:06:30.753Z
question text To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of access to innovative treatments for people living with non-tuberculosis mycobacteria in the UK. more like this
session
2022/23 more like this
session number 3 more like this
tabling member constituency Birmingham, Selly Oak more like this
tabling member printed
Steve McCabe more like this
title House of Commons Tabled Parliamentary Question 2022/23 62682 more like this
type
WrittenParliamentaryQuestion
uin 62682 more like this
version 2 remove filter
written parliamentary question type NamedDay more like this
answer answer
creator
298
label Biography information for Steve McCabe more like this
publisher 25259
tabling member
298
label Biography information for Steve McCabe more like this